Cargando…

Identifying Therapeutic Targets for Spinocerebellar Ataxia Type 3/Machado–Joseph Disease through Integration of Pathological Biomarkers and Therapeutic Strategies

Spinocerebellar ataxia type 3/Machado–Joseph disease (SCA3/MJD) is a progressive motor disease with no broadly effective treatment. However, most current therapies are based on symptoms rather than the underlying disease mechanisms. In this review, we describe potential therapeutic strategies based...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yu-Shuan, Hong, Zhen-Xiang, Lin, Shinn-Zong, Harn, Horng-Jyh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246822/ https://www.ncbi.nlm.nih.gov/pubmed/32357546 http://dx.doi.org/10.3390/ijms21093063

Ejemplares similares

High frequency of Machado-Joseph disease identified in Southeastern Chinese kindreds with spinocerebellar ataxia
por: Gan, Shi-Rui, et al.
Publicado: (2010)

Peripheral Oxidative Stress Biomarkers in Spinocerebellar Ataxia Type 3/Machado–Joseph Disease
por: de Assis, Adriano M., et al.
Publicado: (2017)

Neural correlates of ataxia severity in spinocerebellar ataxia type 3/Machado-Joseph disease
por: Hernandez-Castillo, Carlos R., et al.
Publicado: (2017)

Dystonia in Patients with Spinocerebellar Ataxia 3 - Machado-Joseph disease: An Underestimated Diagnosis?
por: Catai, Ligia Maria Perrucci, et al.
Publicado: (2018)

Recurrent divergence-insufficiency esotropia in Machado-Joseph disease (spinocerebellar ataxia type 3)
por: Stallworth, Jeannette Y., et al.
Publicado: (2022)

Epidemiological, clinical, and molecular characterization of Cuban families with spinocerebellar ataxia type 3/Machado-Joseph disease
por: González-Zaldívar, Yanetza, et al.
Publicado: (2015)

Spinocerebellar ataxia type 3/Machado-Joseph disease manifested as spastic paraplegia: A clinical and genetic study
por: SONG, YANMIN, et al.
Publicado: (2015)

n-Butylidenephthalide Modulates Autophagy to Ameliorate Neuropathological Progress of Spinocerebellar Ataxia Type 3 through mTOR Pathway
por: Lee, Jui-Hao, et al.
Publicado: (2021)

The blood-brain barrier is disrupted in Machado-Joseph disease/spinocerebellar ataxia type 3: evidence from transgenic mice and human post-mortem samples
por: Duarte Lobo, Diana, et al.
Publicado: (2020)

Cerebellar morphometric and spectroscopic biomarkers for Machado-Joseph Disease
por: Miranda, Catarina Oliveira, et al.
Publicado: (2022)

Therapeutic Strategies for Spinocerebellar Ataxia Type 1
por: Kerkhof, Laurie M. C., et al.
Publicado: (2023)

Familial spontaneous pneumothorax and Machado–Joseph disease
por: Pelayo, Jerald, et al.
Publicado: (2020)

Human Olfactory Ensheathing Cell Transplantation Improves Motor Function in a Mouse Model of Type 3 Spinocerebellar Ataxia
por: Hsieh, Jeanne, et al.
Publicado: (2017)

State biomarkers for Machado Joseph disease: Validation, feasibility and responsiveness to change
por: Furtado, Gabriel Vasata, et al.
Publicado: (2019)

Cell-based therapeutic strategies for treatment of spinocerebellar ataxias: an update
por: Correia, Joana Sofia, et al.
Publicado: (2022)

Cerebellar Rotation Abnormalities Observed in Machado-Joseph Disease
por: Nomura, Taichi, et al.
Publicado: (2020)

Tissue-Specific Vulnerability to Apoptosis in Machado-Joseph Disease
por: Ferreira, Ana F., et al.
Publicado: (2023)

Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias
por: Buijsen, Ronald A.M., et al.
Publicado: (2019)

Machado-Joseph Disease: from first descriptions to new perspectives
por: Bettencourt, Conceição, et al.
Publicado: (2011)

Fibroblasts of Machado Joseph Disease patients reveal autophagy impairment
por: Onofre, Isabel, et al.
Publicado: (2016)

Trehalose alleviates the phenotype of Machado–Joseph disease mouse models
por: Santana, Magda M., et al.
Publicado: (2020)

Profiling Microglia in a Mouse Model of Machado–Joseph Disease
por: Campos, Ana Bela, et al.
Publicado: (2022)

T2-hyperintensity in the internal globus pallidus in Machado-Joseph disease
por: Meira, Alex T., et al.
Publicado: (2023)

Myelinating Glia: Potential Therapeutic Targets in Polyglutamine Spinocerebellar Ataxias
por: Putka, Alexandra F., et al.
Publicado: (2023)

Autophagy in Spinocerebellar Ataxia Type 3: From Pathogenesis to Therapeutics
por: Paulino, Rodrigo, et al.
Publicado: (2023)

Clinical manifestations and gene mutation in a case of Machado-Joseph disease★
por: Zhang, Bin, et al.
Publicado: (2012)

Machado-Joseph Deubiquitinases: From Cellular Functions to Potential Therapy Targets
por: Zeng, Chenming, et al.
Publicado: (2020)

Sentinel Node Biopsy and Lumpectomy in a Patient with Machado–Joseph Disease
por: Aldawoodi, N. N., et al.
Publicado: (2019)

Neuropeptide Y (NPY) intranasal delivery alleviates Machado–Joseph disease
por: Duarte-Neves, Joana, et al.
Publicado: (2021)

Genome-wide association study identifies genetic factors that modify age at onset in Machado-Joseph disease
por: Akçimen, Fulya, et al.
Publicado: (2020)

Ataxin-3 and Its E3 Partners: Implications for Machado–Joseph Disease
por: Durcan, Thomas M., et al.
Publicado: (2013)

Nystagmus as an early ocular alteration in Machado-Joseph disease (MJD/SCA3)
por: Raposo, Mafalda, et al.
Publicado: (2014)

Is the High Frequency of Machado-Joseph Disease in China Due to New Mutational Origins?
por: Li, Tianjiao, et al.
Publicado: (2019)

The Homogeneous Azorean Machado-Joseph Disease Cohort: Characterization and Contributions to Advances in Research
por: Lima, Manuela, et al.
Publicado: (2023)

What is the best way to keep walking and moving around for individuals with Machado-Joseph disease? A scoping review through the lens of Aboriginal families with Machado-Joseph disease in the Top End of Australia
por: Carr, Jennifer J, et al.
Publicado: (2019)

Machado-Joseph disease in a Sudanese family links East Africa to Portuguese families and allows reestimation of ancestral age of the Machado lineage
por: Martins, Sandra, et al.
Publicado: (2023)

A Variant in Genes of the NPY System as Modifier Factor of Machado-Joseph Disease in the Chinese Population
por: Ding, Dongxue, et al.
Publicado: (2022)

An understanding of spinocerebellar ataxia
por: Ramachandra, N.B., et al.
Publicado: (2015)

Parkinsonism in Spinocerebellar Ataxia
por: Park, Hyeyoung, et al.
Publicado: (2015)

Spinocerebellar ataxia: an update
por: Sullivan, Roisin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_elsn15iadc6bl9nlne220l5419